ERBB2 and breast carcinoma: We previously demonstrated that HDAC5 negatively regulates the expression of the microRNA molecule, miR-125a-5p, and the overexpression of miR-125a-5p decreases the expression of ERBB2 in ER+ breast cancer cells 15.